Risk of contact infection after intranasal rubella vaccination.
D000281:Administration, Intranasal; D002353:Carrier State / Q000382:microbiology; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007398:Interpersonal Relations; D009666:Nose / Q000382:microbiology; D010614:Pharynx / Q000382:microbiology; D011247:Pregnancy; D012306:Risk; D012409:Rubella / Q000382:microbiology / Q000635:transmission*; D012411:Rubella Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D012412:Rubella virus / Q000472:pathogenicity
D012411:Rubella Vaccine